参考文献/References:
[1] VAINCHENKER W, KRALOVICS R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms[J]. Blood, 2017, 129(6):667-679.
[2] ARBER D A, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-2405.
[3] RUMI E, CAZZOLA M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms[J]. Blood, 2017, 129(6): 680-692.
[4] 李菲菲, 尤崇革.基于高分辨率熔解分析的基因分型新技术[J].现代检验医学杂志, 2011, 26(6): 159-161. LI Feifei, YOU Chongge. New genotyping techniques based on high resolution melting[J]. Journal of Modern Laboratory Medicine, 2011, 26(6): 159-161.
[5] 郑昭璟, 傅启华, ZHOU Luming.高分辨熔解曲线分析技术的发展与展望[J]. 中华检验医学杂志,2017, 40(2): 77-79. ZHENG Zhaojing, FU Qihua, ZHOU Luming. The development and prospects of high-resolution melting analysis[J]. Chinese Journal of Laboratory Medicine, 2017, 40(2): 77-79.
[6] RAPADO I, GRANDE S, ALBIZUA E, et al. High resolution melting analysis for JAK2 exon 14 and exon 12 mutations: a diagnostic Tool for myeloproliferative neoplasms[J]. The Journal of Molecular Diagnostics, 2009, 11(2): 155-161.
[7] LIM K H, LIN H C, CHEN C G S, et al. Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis[J]. Clinica Chimica Acta, 2015, 440: 133-139.
[8] NUSSENZVEIG R H, PHAM H T, PERKINS S L, et al. Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden[J]. Leukemia & Lymphoma, 2016, 57(6): 1429-1435.
[9] MATSUMOTO N, MORI S, HASEGAWA H, et al. Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting[J]. Clinica Chimica Acta, 2016, 462:166-173.
[10] MATSUDA K. PCR-based detection methods for single-nucleotide polymorphism or mutation: realtime PCR and its substantial contribution toward technological refinement [J]. Adv Clin Chem, 2017, 80:45-72.
[11] PARK J, SONG M, JANG W, et al. Peptide nucleic acid probe-based fluorescence melting curve analysis for rapid screening of common JAK2, MPL, and CALR mutations[J]. Clinica Chimica Acta, 2017, 465: 82-90.